Significance of tissue polypeptide antigen (TPA) levels in nasopharyngeal cancer.
Ann Acad Med Singap
; 19(2): 156-60, 1990 Mar.
Article
em En
| MEDLINE
| ID: mdl-2346288
ABSTRACT
Serum levels of tissue polypeptide antigen (TPA) were measured in 233 patients at the time of initial diagnosis of nasopharyngeal carcinoma (NPC). Staging of NPC was done using Ho's recommendations together with computerised tomography (CT) of skull findings. The upper limit of normal serum TPA levels in our population was noted to be 112 U/1. In 126 patients with N0 and N1 lymph node staging, the mean level of TPA was 90 U/1 +/- 9 (standard error of mean, sem), while in 107 patients with N2 and N3 nodal disease the mean was 193 U/1 +/- 25.6 (p less than 0.001). Similarly, in 162 patients with T1 and T2 disease, the average TPA level was 119 +/- 13.4 while in 71 patients with T3 disease, the mean TPA was 179 U/1 +/- 29.8 (p less than 0.03). Of 200 patients without metastases, the mean TPA level was 112 +/- 12 U/l whereas in 33 patients with known metastases in liver, lung, bone or brain, the mean TPA level was 290 +/- 51 (p less than 0.001) with liver metastases producing the highest levels. The present study indicates rising values of TPA with advancing nodal and tumour stage in NPC, with high values in metastatic disease. There is a highly significant correlation between nodal stage and TPA levels. TPA is a useful marker in the staging and follow-up of NPC patients.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Peptídeos
/
Neoplasias Nasofaríngeas
Idioma:
En
Ano de publicação:
1990
Tipo de documento:
Article